Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.34
-0.27 (-0.94%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25,641,265
Open
28.50
Bid (Size)
28.35 (4)
Ask (Size)
28.36 (3)
Prev. Close
28.61
Today's Range
28.26 - 28.52
52wk Range
25.20 - 34.11
Shares Outstanding
5,606,688,356
Dividend Yield
5.79%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Behind the Scenes of Pfizer's Latest Options Trends
Today 12:20 EDT
Via
Benzinga
Key Takeaways From Pfizer Analyst Ratings
Today 11:01 EDT
Via
Benzinga
Performance
YTD
-4.68%
-4.68%
1 Month
+0.14%
+0.14%
3 Month
+2.31%
+2.31%
6 Month
+4.11%
+4.11%
1 Year
-16.40%
-16.40%
More News
Read More
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Today 10:22 EDT
Via
Benzinga
Is Pfizer a Buy Right Now or a Value Trap?
Today 5:20 EDT
Via
The Motley Fool
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
October 02, 2024
Via
Benzinga
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
October 02, 2024
Via
The Motley Fool
Pfizer Unusual Options Activity
September 24, 2024
Via
Benzinga
Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?
October 02, 2024
Via
The Motley Fool
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
Via
Benzinga
Exposures
COVID-19
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
Via
Investor Brand Network
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
Via
FinancialNewsMedia
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
October 01, 2024
Via
Benzinga
Top 3 Discounted Value Stocks Worth Buying Now
September 30, 2024
Via
Talk Markets
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
Via
Benzinga
Exposures
Product Safety
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
September 30, 2024
Via
Benzinga
Exposures
COVID-19
Is Summit Therapeutics Stock a Buy?
September 30, 2024
Via
The Motley Fool
15 Best Dividend Stocks for Lifelong Passive Income
September 30, 2024
Via
The Motley Fool
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Via
The Motley Fool
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
September 26, 2024
Via
Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Via
Investor's Business Daily
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
September 26, 2024
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
September 26, 2024
Via
The Motley Fool
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
September 25, 2024
From
Pfizer Inc.
Via
Business Wire
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
September 25, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.